Evidence map›Paper›PMID 16142231›Full record

ArticleNature genetics2005

Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

Yeong-Gwan Park, Xiaohong Zhao, Fabienne Lesueur, Douglas R Lowy, Mindy Lancaster, Paul Pharoah, Xiaolan Qian, Kent W Hunter

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 1 synthesis or guideline pooled it, 178 citations in OpenAlex.

  1. The association of SIPA1 gene polymorphisms with breast cancer risk: evidence from published studies.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Pooled it
  2. Article
  3. Article
  4. Impact ofCancers · 2024
    Article
  5. SMARCD1 is a "Goldilocks" metastasis modifier.bioRxiv : the preprint server for biology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. A scan for genes associated with cancer mortality and longevity in pedigree dog breeds.Mammalian genome : official journal of the International Mammalian Genome Society · 2020
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Yeong-Gwan ParkLaboratory of Population Genetics, National Cancer Institute, Building 41, Room 702, 41 Library Drive, Bethesda, Maryland 20892, USA.
Xiaohong Zhao
Fabienne Lesueur
Douglas R Lowy
Mindy Lancaster
Paul Pharoah
Xiaolan Qian
Kent W Hunter
National Cancer Institute · USHutchison/MRC Research Centre · GBKorean Intellectual Property Office · KR

Funding

GENETIC MODIFIERS OF MAMMARY CANCER INITIATION/ PROGRESSZ01CP010146 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI HUNTER, KENT WILLIAM · 2000 to 2008
$3.3M
TUMOR GENE EXPRESSION IN VITRO AND IN VIVOZ01BC008905 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LOWY, DOUGLAS R. · 1996 to 2008
$1.2M
Intramural NIH HHSNCI NIH HHS Z01 CP010146-06
6 · The paper itself

Abstract

We previously identified loci in the mouse genome that substantially influence the metastatic efficiency of mammary tumors. Here, we present data supporting the idea that the signal transduction molecule, Sipa1, is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Analysis of candidate genes identified a nonsynonymous amino acid polymorphism in Sipa1 that affects the Sipa1 Rap-GAP function. Spontaneous metastasis assays using cells ectopically expressing Sipa1 or cells with knocked-down Sipa1 expression showed that metastatic capacity was correlated with cellular Sipa1 levels. We examined human expression data and found that they were consistent with the idea that Sipa1 concentration has a role in metastasis. Taken together, these data suggest that the Sipa1 polymorphism is one of the genetic polymorphisms underlying the Mtes1 locus. This report is also the first demonstration, to our knowledge, of a constitutional genetic polymorphism affecting tumor metastasis.

Indexed as

Polymorphism, GeneticAnimalsBiological AssayCell AdhesionChlorocebus aethiopsCOS CellsGTPase-Activating ProteinsHumansMiceMutationNeoplasm MetastasisNuclear Proteinsrap GTP-Binding ProteinsRNA, Small InterferingTranscriptional ActivationGTPase-Activating ProteinsNuclear Proteinsrap GTP-Binding ProteinsRNA, Small InterferingSIPA1 protein, humanSipa1 protein, mouse

Identifiers

PMID16142231
PMCPMC2140048
OpenAlexW2081015231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.